Population-based Canadian hip fracture rates with international comparisons
- PMID: 19802507
- PMCID: PMC5101056
- DOI: 10.1007/s00198-009-1080-1
Population-based Canadian hip fracture rates with international comparisons
Abstract
Summary: We identified hospitalizations throughout Canada during 2000-2005 in which the most responsible diagnosis was a proximal femoral fracture. Use of the US fracture risk assessment tool (FRAX) would be inappropriate for Canada as it would overestimate fracture risk in Canadian women and older men.
Introduction: It is recommended that the WHO fracture risk assessment tool should be calibrated to the target population.
Methods: We identified hospitalizations for women and men throughout Canada during the study period 2000-2005 in which the most responsible diagnosis was a proximal femoral fracture (147,982 hip fractures). Age-standardized hip fracture rates were compared between Canadian provinces, and national rates were compared with those reported for the USA and Germany.
Results: There were relatively small differences in hip fracture rates between provinces, and most did not differ appreciably from the Canadian average. Hip fracture rates for women in Canada in 2001 were substantially lower than in the USA (population-weighted rate ratio 0.70) and were also lower than in Germany for 2004 (population-weighted rate ratio 0.74).
Conclusions: Overall hip fracture rates for Canadian women were found to be substantially lower than those for the USA and Germany. This study underscores the importance of assessing country-specific fracture patterns prior to adopting an existing FRAX tool.
Conflict of interest statement
William D. Leslie: honoraria for lectures from Merck Frosst Canada and unrestricted educational and research grants from Merck Frosst Canada, Sanofi-Aventis, Procter & Gamble Pharmaceuticals Canada, Inc., Novartis Pharmaceuticals Canada, Inc., Amgen Canada, and Genzyme Canada Ltd. Kerry Siminoski: honoraria for lectures in the past year from Procter and Gamble Pharmaceuticals and Sanofi-Aventis and research support from Merck Frosst, Procter & Gamble Pharmaceuticals, and Sanofi-Aventis. Stephanie Kaiser: honoraria in the past year from Sanofi-Aventis, Procter & Gamble, Servier Canada, Novartis Pharmaceuticals Canada, Inc., Amgen Canada, Eli Lilly Canada, and Astra Zeneca Canada and unrestricted educational and research grants from Sanofi-Aventis, Procter & Gamble, Novartis Pharmaceuticals Canada, Inc., and Servier Canada. David L. Kendler: Speakers Bureau, educational grants, advisory boards, and/or research grants from Merck Frosst, Sanofi-Aventis, Procter & Gamble Pharmaceuticals Canada, Inc., Novartis Pharmaceuticals Canada, Inc., Amgen Canada, Eli Lilly Canada Ltd., Nycomed Canada Ltd., Pfizer Canada Ltd., Servier Canada Ltd., GSK Canada Ltd., Biosante Ltd, J and J Canada Ltd., and Zelos Canada Ltd.
Similar articles
-
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2. Epub 2010 Dec 16. Osteoporos Int. 2011. PMID: 21161509
-
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.Osteoporos Int. 2011 Mar;22(3):829-37. doi: 10.1007/s00198-010-1465-1. Epub 2010 Dec 16. Osteoporos Int. 2011. PMID: 21161508 Free PMC article.
-
Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.Arch Osteoporos. 2013;8:145. doi: 10.1007/s11657-013-0145-0. Epub 2013 Aug 9. Arch Osteoporos. 2013. PMID: 23929269
-
Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.Syst Rev. 2023 Mar 21;12(1):51. doi: 10.1186/s13643-023-02181-w. Syst Rev. 2023. PMID: 36945065 Free PMC article.
-
Systematic review of major osteoporotic fracture to hip fracture incidence rate ratios worldwide: implications for Fracture Risk Assessment Tool (FRAX)-derived estimates.J Bone Miner Res. 2021 Oct;36(10):1942-1956. doi: 10.1002/jbmr.4395. Epub 2021 Jul 31. J Bone Miner Res. 2021. PMID: 34152628 Free PMC article.
Cited by
-
Denosumab: mechanism of action and clinical outcomes.Int J Clin Pract. 2012 Dec;66(12):1139-46. doi: 10.1111/ijcp.12022. Epub 2012 Sep 12. Int J Clin Pract. 2012. PMID: 22967310 Free PMC article. Review.
-
The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service.Osteoporos Int. 2016 Dec;27(12):3439-3447. doi: 10.1007/s00198-016-3669-5. Epub 2016 Jul 1. Osteoporos Int. 2016. PMID: 27368699 Free PMC article.
-
Comparisons of reference curves for femoral neck geometric parameters between Changsha-Chinese women and women of three ethnic groups in the United States.Arch Osteoporos. 2025 Jul 8;20(1):86. doi: 10.1007/s11657-025-01571-y. Arch Osteoporos. 2025. PMID: 40627087 Free PMC article.
-
Survey of Current Practices: Peripheral Nerve Block Utilization by ED Physicians for Treatment of Pain in the Hip Fracture Patient Population.Can Geriatr J. 2013;16(1):16-21. doi: 10.5770/cgj.16.52. Epub 2013 Mar 4. Can Geriatr J. 2013. PMID: 23440013 Free PMC article.
-
Comparison of femoral neck geometric parameters between Chinese and Japanese females.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Mar 28;47(3):319-327. doi: 10.11817/j.issn.1672-7347.2022.210456. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35545324 Free PMC article. Chinese, English.
References
-
- Tenenhouse A, Joseph L, Kreiger N, et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos) Osteoporos Int. 2000;11:897–904. - PubMed
-
- Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003;18:1947–1954. - PubMed
-
- Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–1733. - PubMed
-
- Kanis JA, Johnell O, De Laet C, et al. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17:1237–1244. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical